Your browser doesn't support javascript.
loading
A phase II study of omacetaxine mepesuccinate for patients with higher-risk myelodysplastic syndrome and chronic myelomonocytic leukemia after failure of hypomethylating agents.
Short, Nicholas J; Jabbour, Elias; Naqvi, Kiran; Patel, Ami; Ning, Jing; Sasaki, Koji; Nogueras-Gonzalez, Graciela M; Bose, Prithviraj; Kornblau, Steven M; Takahashi, Koichi; Andreeff, Michael; Sanchez-Petitto, Gabriela; Estrov, Zeev; Dinardo, Courtney D; Montalban-Bravo, Guillermo; Konopleva, Marina; Alvarado, Yesid; Bhalla, Kapil N; Fiskus, Warren; Khouri, Maria; Islam, Rubiul; Kantarjian, Hagop; Garcia-Manero, Guillermo.
Afiliação
  • Short NJ; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Jabbour E; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Naqvi K; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Patel A; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Ning J; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Sasaki K; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Nogueras-Gonzalez GM; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Bose P; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Kornblau SM; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Takahashi K; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Andreeff M; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Sanchez-Petitto G; Department of Internal Medicine, The University of Texas Health Science Center at Houston, Houston, Texas.
  • Estrov Z; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Dinardo CD; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Montalban-Bravo G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Konopleva M; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Alvarado Y; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Bhalla KN; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Fiskus W; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Khouri M; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Islam R; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Kantarjian H; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Garcia-Manero G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Am J Hematol ; 94(1): 74-79, 2019 01.
Article em En | MEDLINE | ID: mdl-30328139
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndromes Mielodisplásicas / Leucemia Mielomonocítica Crônica / Mepesuccinato de Omacetaxina / Antineoplásicos Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndromes Mielodisplásicas / Leucemia Mielomonocítica Crônica / Mepesuccinato de Omacetaxina / Antineoplásicos Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article